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Abstract
Background: DNA damage (single or double-strand breaks) triggers adapted cellular responses. These responses
are elicited through signalling pathways, which activate cell cycle checkpoints and basically lead to three cellular
fates: cycle arrest promoting DNA repair, senescence (permanent arrest) or cell death. Cellular senescence is known
for having a tumour-suppressive function and its regulation arouses a growing scientific interest. Here, we advance
a qualitative model covering DNA damage response pathways, focusing on G1/S checkpoint enforcement,
supposedly more sensitive to arrest than G2/M checkpoint.
Results: We define a discrete, logical model encompassing ATM (ataxia telangiectasia mutated) and ATR (ATM and
Rad3-related) pathways activation upon DNA damage, as well as G1/S checkpoint main components. It also
includes the stress responsive protein p38MAPK (mitogen-activated protein kinase 14) known to be involved in the
regulation of senescence. The model has four outcomes that convey alternative cell fates: proliferation, (transient)
cell cycle arrest, apoptosis and senescence. Different levels of DNA damage are considered, defined by distinct
combinations of single and double-strand breaks. Each leads to a single stable state denoting the cell fate adopted
upon this specific damage. A range of model perturbations corresponding to gene loss-of-function or gain-of-
function is compared to experimental mutations.
Conclusions: As a step towards an integrative model of DNA-damage response pathways to better cover the
onset of senescence, our model focuses on G1/S checkpoint enforcement. This model qualitatively agrees with
most experimental observations, including experiments involving mutations. Furthermore, it provides some
predictions.
Background
Numerous checkpoints ensure the correct progression
along the phases (G0, G1, S, G2, M) of the eukaryotic cell
cycle [1]. DNA damage response pathways activate
checkpoints to arrest the cell cycle transiently, promoting
DNA repair, or permanently, inducing senescence or cell
death [2]. DNA damage consists of DNA single-strand
breaks (SSB) and double-strand breaks (DSB) that pre-
sent a threat to structural chromosome stability and are
thus the main inducers of DNA damage response [2].
This response to specific DNA damage is an evolutionary
program that prevents the propagation of incorrect geno-
mic information. Mammalian senescence, a less under-
stood complex phenotype, is associated to aging and
tumorigenesis [3,4]. The secretory phenotype associated
with the senescent state includes growth factors that
affect cells and tissues by activating membrane receptors
whose deregulation is responsible for numerous patholo-
gies, including cancer [5,6].
Upon DNA damage, the mechanisms driving the deci-
sion between these different cell fates are still unclear and,
partly due to a manifest medical impact, they are the sub-
ject of high interest (e.g., [7,8]). In particular, how cells are
induced to senescence upon DNA damage attracted a lot
of attention, this phenotype being associated to tumour
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suppression [9]. Here, we propose to resort to a qualitative
modelling approach to investigate these mechanisms.
A variety of modelling frameworks offer complementary
tools to integrate current knowledge in the form of com-
putational models that provide insights into biological pro-
cesses (e.g., [10-13]). Recently, several groups have
approached cell fate decision from different modelling per-
spectives, from differential equations to discrete models.
Among other components, the tumour suppressor p53
protein triggers cellular programs that lead to different
fates: transient arrest followed by cell cycle re-entry upon
damage repair, permanent cell cycle arrest (senescence)
or, if the damage is irreparable, initiation of cell death
program (apoptosis). To investigate the decision between
G1 arrest and apoptosis, Zhang et al. proposed a modular
model of the p53 network, using ordinary differential
equations [9]. The model defined by Iwamoto et al. also
comprises p53 together with cell cycle regulation allow-
ing to investigate the impact of DNA damage intensities
on cell cycle progression [14]. Purvis and co-workers pro-
posed a model based on delayed differential equations to
further study how p53 dynamics influences the decision
between apoptosis and senescence [15].
In contrast to these continuous models, discrete, logical
formalisms were used to tackle the study of networks
implicated in cell cycle control (see [16] for a review) as
well as in cell fate decision [17-20]. Calzone et al. [19]
advanced with a model of cell fate decision with death and
survival receptors as input signals, downstream pathways
and three cellular outcomes: survival, apoptosis and necro-
sis. Also relying on a logical approach, Poltz and Naumann
devised a model to study the inflammation contribution to
DNA damage response leading to cell cycle arrest or apop-
tosis [18]. Finally, the recent model from Grieco et al.
accounts for the influence of the stress responsive mito-
gen-activated protein kinase pathway (MAPK) on cancer
cell fate decision [20].
Searching the literature and partly building on the
network of human G1/S checkpoint activation [2], we
propose a logical model of cell fate decision upon DNA
damage, including proliferation, transient arrest for
DNA repair, apoptosis and, notably, senescence. This
precursory model extends the regulatory pathway of G1/
S checkpoint activation with the inclusion of the stress
responsive protein p38MAPK (mitogen-activated protein
kinase 14) that plays an important role in senescence
[7,8,21].
The paper is organised as follows. After a brief over-
view of main biological facts, our model is defined and
analysed in the Results section. The Conclusion section
is devoted to further discussion of the model properties
and includes future work. The logical modelling frame-
work is described in the Methods section.
Results and discussion
We briefly describe biological facts at the core of the
regulatory network of Figure 1, the corresponding logi-
cal model being then thoroughly defined. This section
ends with the model analysis, in terms of cell fates for
the wild type situation and a range of perturbations.
In what follows, we first introduce well-established
molecular processes responsible for G1/S checkpoint
and apoptosis activation. Then, as the main novelty of
our work, we describe additional players involved in reg-
ulating human cellular senescence through G1/S check-
point activation.
G1/S checkpoint and apoptosis (Figure 1-A)
Presence of DNA damage activates checkpoints, halting
progression of the cell cycle [2,22]. Arrest for repair,
apoptosis or senescence can be triggered both at G1/S
and G2/M checkpoints. In the case of senescence-
induced DNA damage, it was suggested that G1/S
checkpoint is more sensitive and that a single DSB can
induce arrest, while a larger number is required to acti-
vate G2/M checkpoint [23]. Molecular machineries
sense DNA strand breaks and activate the kinases ataxia
telangiectasia mutated (ATM) and Rad3-related (ATR)
and consequently downstream pathways involving the
activation of p53 [22,23]. ATM is activated by DSB
while ATR is activated by either SSB or DSB, and they
both trigger a cascade of phosphorylations accounting
for most of the interactions represented in Figure 1[2,8].
ATM phosphorylates the kinases checkpoint kinase 2
(CHEK2) while ATR phosphorylates the kinases check-
point kinase 1 (CHEK1). CHEK1 and CHEK2 initiate
the cell cycle arrest by phosphorylating cell division
cycle 25A protein (CDC25A) that prevents the depho-
sphorylation of the protein complexes cyclin-dependent
kinase 4, 6 and cyclin D (Cdk4/6-Cyclin-D) and cyclin-
dependent kinase 2 and cyclin E (Cdk2/Cyclin-E). This
also prevents the phosphorylation of retinoblastoma 1
protein (RB1) and the release of E2F transcription fac-
tors that induce the expression of genes required for the
cell to enter S phase [2]. ATR, ATM, CHEK1 and
CHEK2 phosphorylate p53 that mediates the mainte-
nance of G1/S arrest through the activation of cyclin-
dependent kinase inhibitor 1A (p21), which in turns
inhibits Cdk4/6-Cyclin-D and Cdk2/Cyclin-E [24,25].
Upon DNA repair, the complex Cdk2/Cyclin-E is acti-
vated and drives the cell from G1 to S phase.
Decision between growth arrest and apoptosis is
mediated through a pivotal threshold mechanism related
to the activation level of p53 that, when surpassed, trig-
gers apoptosis at G1/S checkpoint [26]. The locus
CDKN2A contributes to cell cycle regulation through its
two products: p14ARF (the alternate reading frame
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product), which promotes p53 and p16INK4a involved in
senescence (see below) [4,27]. The regulatory module
involving E3 ubiquitin protein ligase homolog (Mdm2)
and p14ARF tightly controls p53; Mdm2 promotes p53
degradation, while Mdm2 is sequestered by p14ARF to
decrease p53 degradation [27]. In our model, apoptosis
is oversimplified; it is activated when p53 reaches its
highest level.
Senescence (Figure 1-B)
The regulation of the senescent state, although less
understood, is known to be associated with the activa-
tion in several cell types of the p53-p21 pathway (that
stabilizes the arrest, see above) and of the p16INK4a-RB1
pathway [4,7,21].
Cyclin-dependent kinase inhibitor 2A (p16INK4a) con-
tributes along with p53 to block cancer progression
since it inhibits the complex Cdk4/6-Cyclin-D required
for proliferation. The overexpression of p16INK4a can
induce a senescent arrest in several human cell types
[4,7]. The exact mechanisms of regulation of p16INK4a (a
product of CDKN2A locus) are still unclear, however
p38MAPK is involved somehow [21,28,29].
p38MAPK is a component of the ATM/ATR depen-
dent MAPK stress responsive pathway. Besides regulating
the locus CDKN2A, p38MAPK activates p53 leading to
arrest or apoptosis and inhibits Cdc25A required for pro-
liferation [8,30,31]. Overexpression of p38MAPK induces
senescence even in the absence of DNA damage [32].
Logical model
Relying on the aforementioned biological evidences, and
focusing on the inclusion of senescence as an additional
outcome of the checkpoint arrest, we delineate a logical
version of the regulation of the G1/S checkpoint. A descrip-
tion of the modelling framework is provided in the Meth-
ods section.
The network of Figure 1 should be seen as a generic
wiring since senescence requires the involvement of
both p16INK4a-RB1 and p53-p21 pathways in several
cell types [4]. Table 1 includes a brief documentation
of the network nodes. The logical rules governing the
states of the nodes briefly described below are given in
Table 2.
SSB and DSB, the two input nodes of the network,
take three values corresponding to damage intensities: 0
for no damage, 1 for a reparable damage and 2 for an
irreparable damage. SSB and DSB levels determine the
ATR and ATM levels, respectively, which in turn acti-
vate CHEK2, CHEK1, p38MAPK and p53.
Figure 1 Regulatory network of cell-fate decision upon DNA damage involving (A) the G1/S checkpoint arrest network and (B) the
senescence regulatory pathway. Rectangular nodes indicate Boolean components, whereas ellipses represent multi-valued components; green
arrows represent activations and red bar arrows inhibitions. Input nodes (dark grey ellipses) SSB and DSB stand for single and double DNA-strand
breaks respectively. Output nodes (white rectangles) correspond to the four different outcomes (cell fates). Internal nodes embody the main
regulators of the fate decision.
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The criterion for the activation of the ‘proliferation’
node (representing no arrest and transition to the S
phase) is the activation of CDK2CycE. The ‘cycle_arrest’
node, denoting a transient arrest for repair, is ON in the
absence of CDK2CycE.
Components p53 and p38MAPK have 3 and 4 levels,
respectively, and play a central role in the network proces-
sing. The presence of intermediary DNA damage induces
p53 to its intermediary level (p53 = 1) that is involved in
several fates. To trigger apoptosis, p53 must reach its high-
est value (p53 = 2) [26]. In the model, this only occurs in
case of fully irreparable DNA damage: DSB=SSB = 2.
p38MAPK affects cell fate decision through its interac-
tions with p53, p16INK4a and p14ARF. ATM has a stronger
positive influence on p38MAPK than ATR [30]. Its first
positive level (1) is reached when ATR is present or when
ATM is present but not at its highest level. p38MAPK is
at level 2 when ATM is at its maximum level but not
ATR. When both ATM and ATR are at their maximum
levels, i.e. in the case of fully irreparable DNA damage,
p38MAPK reaches its highest level (3).
As previously mentioned, ‘senescence’ is regulated
simultaneously by the p53-p21 and p16INK4a-RB1 path-
ways and corresponds to a permanent arrest where pro-
teins involved in cell cycle progression are inhibited,
especially CDC25A. Therefore, we consider that the
activation of the fate ‘senescence’ requires both positive
influences from p21 and p16INK4a, the absence of
CDC25A and p53 not at its highest level. However, in the
presence of CDC25A, senescence is activated provided
p16INK4a is at its highest level 2. Such a p16INK4a signifi-
cant overexpression, has been experimentally observed
[33]. It was suggested that CHEK1 and CHEK2 may not
have redundant roles in CDC25A regulation [34]. Accord-
ingly, CDC25A has 3 levels; its ‘full’ inactivation being
achieved only in the presence of CHEK1, CHEK2 and
p38MAPK. In what follows, we analyse the model out-
comes, given by its stable states, for the wild-type situation
and a range of relevant perturbations.
Model stable states: wild type case
Figure 2 displays the stable states of the model, in which
all component values are maintained (see Methods sec-
tion). Each type of DNA damage, described by the combi-
nation of the different levels of the input nodes DSB and
SSB, defines a unique stable state, in which the values of
the output nodes embody the cell fates (’proliferation’,
‘apoptosis’, ‘senescence’, ‘cycle_arrest’). In the absence of
DNA damage, the outcome is ‘proliferation’ and in this
stable state, the only active components are those involved
in cell cycle progression. In the case of reparable damage,
described by SSB or DSB = 1, the model outcome is
‘cycle_arrest’, interpreted as a transient arrest for repair
that requires the inhibition of CDK2CycE.
The node ‘senescence’ is activated when DSB = 2 and
SSB<2 as irreparable SSB does not induce senescence
[4,23]. When activated, ‘senescence’ is accompanied by
‘cycle_arrest’. For SSB=DSB = 2, ‘apoptosis’ is activated by
the high level of p53 (and accompanied by ‘cycle_arrest’).
Summarising, the stable states of our model, in the wild
type situation, are consistent: no damage leads to prolifera-
tion, high levels of DSB and SSB cause apoptosis, and all
other combinations of levels of DSB or SSB induce senes-
cence or transient cycle arrest.
Model stable states: mutant cases
We briefly present the results obtained for a series of in
silico perturbations that correspond to loss-of-function
(LoF) or gain-of-function (GoF) experiments. The full
set of stable states of each perturbation is listed in the
Supplementary Material 1 to this article. Table 3 recapi-
tulates the comparisons between the model outcomes
and experimental data for mutant cells that have under-
gone (or not) DNA damage. In these experiments, DNA
damage agents include ionizing radiation or carcino-
genic chemicals. We searched for experiments preferen-
tially dealing with human cells, but some mutations
were found only in mice. Additionally, when data at the
cellular level are lacking, we sometimes refer to the
mutant mice phenotype.
Table 1 Brief molecular description of the model
components
Node Description
SSB Single strand break: 0 (no break), (1) reparable and (2)
irreparable SSB
DSB Double strand break: 0 (no break), (1) reparable and (2)
irreparable DSB
ATR Ataxia telangiectasia and Rad3 related protein
ATM Ataxia telangiectasia mutated protein
CHEK2 Checkpoint kinase 2 protein
CHEK1 Checkpoint kinase 1 protein
p14ARF Alternate reading frame (ARF) protein (from CDKN2A
locus)
p16INK4a Cyclin-dependent kinase inhibitor 2A protein (from
CDKN2A locus)
p38MAPK Mitogen activated protein kinase 14 protein
Mdm2 E3 ubiquitin protein ligase homolog protein
p21 Cyclin-dependent kinase inhibitor 1A protein
p53 Tumor supressor protein p53 protein
CDC25A Cell division cycle 25A protein
E2F E2F transcription factor family of proteins (E2F1, E2F2,
E2F3)
RB1 Retinoblastoma 1 protein
CDK46CycD Protein complex: Cyclin-dependent kinase 4, 6 and Cyclin
D
CDK2CycE Protein complex: Cyclin-dependent kinase 2 and Cyclin E
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Table 2 Logical rules associated with the regulatory network of Fig 1 and interpretation of the multi-levels
Node Rule / level interpretation
ATM 1: DSB = 1 Low level of DSB signal
2: DSB = 2 High level of DSB signal
ATR 1: SSB = 1 Low level of SSB signal
2: SSB = 2 High level of SSB signal
CHEK2 1: ATM = 2
CHEK1 1: ATR = 2 OR ATM = 2
p14ARF 1: p38MAPK = 2 OR E2F
p38MAPK 1: (ATM = 1 OR ATR = 1-2) AND NOT(ATM = 2) Activated p38MAPK pathway (leading to cycle
arrest)
2: ATM = 2 AND NOT(ATR = 2) Middle level of p38MAPK pathway activation
(leading to senescence)
3: ATM = 2 AND ATR = 2 Highest level of p38MAPK pathway activation
(leading to apoptosis)
Mdm2 1: p53 = 1 AND NOT(p14ARF)
p16INK4A 1: p38MAPK = 1-2 Activated p16INK4A
2: p38MAPK = 3 p16 INK4A upregulation
p21 1: p53 = 1
p53 1: Mdm2 = 1 AND (p38MAPK = 3 OR ATR = 1-2 OR ATM = 1-2 OR CHEK1 = 1 OR
CHEK2 = 1)
Activated p53 (no accumulation)
2: NOT(Mdm2 = 1) AND (p38MAPK = 3 OR ATR = 1-2 OR ATM = 1-2 OR CHEK1 =
1 OR CHEK2 = 1)
p53 accumulation leading to apoptosis
CDC25A 1: (p38MAPK = 1-3 OR CHEK2 = 1 OR CHEK1 = 1) AND NOT(p38MAPK = 1-3 AND
CHEK2 = 1 AND CHEK1 = 1)
Low concentration of active Cdc25A (i.e. non-
phosphorylated)
2: NOT(p38MAPK = 1-3) AND NOT(CHEK2 = 1) AND NOT(CHEK1 = 1) High concentration of active Cdc25A
E2F 1: NOT(RB1 = 1)
RB1 1: NOT(CDK46CycDc = 1) AND NOT(CDK2CycEc =1) Dephosphorylated RB1 bound to E2F
CDK46CycD 1: Cdc25A = 1 AND NOT(p16INK4a = 1-2) AND NOT(p21 = 1)
CDK2CycE 1: NOT(p21 = 1) AND Cdc25A = 2 AND E2F = 1
apoptosis 1: p53 = 2
proliferation 1: CDK2CycEc = 1
senescence 1: (p16INK4a = 1 AND p21 = 1 AND NOT(Cdc25A = 1-2) AND NOT(p53 = 2)) OR (p16INK4a = 2 AND p21 = 1 AND NOT(Cdc25A = 2)
AND NOT(p53 = 2))
cyclearrest 1: NOT(CDK2CycEc = 1)
Input components (DSB and SSB) are constant and thus do not appear in this table. Rules are defined using the logical connectors AND, OR and NOT. For each
node, they specify its target value, depending on the state of its regulators. Note that 0 is the default value (selected whenever none of the conditions defined
for other values are verified).
Figure 2 Model stable states for the wild-type situation. Each line corresponds to a stable state characterised by the values of the model
components (listed in the columns). Each combination of SSB and DSB values among the 9 possible combinations (2 right-most columns) leads
to a unique stable state; the corresponding cell fate is defined by the values of the output components (4 left-most columns).
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Table 3 Comparison of model outcomes with experiments for different perturbations
Loss-Of-Function (LoF)
Gene Model outcome Experimental outcome
Comparison with experiments whose protocol include DNA damage
p38MAPK Loss of senescence and of apoptosis Reduced apoptosis [35]
CHEK2 Loss of senescence Loss of senescence [37]
ATM Loss of senescence and of apoptosis Reduced apoptosis [41]
Comparison with experiments whose protocol does not include DNA damage
CHEK1 No damage: proliferation
With damage: loss of senescence
Apoptosis enhanced [42]
p14ARF No damage: proliferation
With damage: senescence enhanced & loss of apoptosis
?
Mdm2 No damage: proliferation
With damage: apoptosis
Apoptosis [45]
p16INK4a No damage: proliferation
With damage: loss of senescence
Loss of senescence
[6,7,21]
p21 No damage: proliferation
With damage: loss of senescence
Proliferation [47]
p53 No damage: proliferation
With damage: loss of senescence & apoptosis
Proliferation & loss of senescence [48]
ATR No damage: proliferation
With damage: senescence enhanced & loss of apoptosis
?
CDC25A No damage: loss of proliferation
With damage: senescence enhanced
?
RB1 No damage: proliferation
With damage: apoptosis
Apoptosis enhanced [50]
E2F No damage: loss of proliferation
With damage: similar to the wild type
Loss of proliferation [51]
p53 &
Mdm2
No damage: proliferation
With damage: loss of senescence & apoptosis
Proliferation [45]
Gain-Of-Function (GoF)
Gene Model outcome Experimental outcome
Comparison with experiments whose protocol include DNA damage
CHEK2 Senescence enhanced Apoptosis & senescence [39,40]
Mdm2 Senescence enhanced & loss of apoptosis Loss of apoptosis [46]
p21 Similar to the wild type Loss of proliferation or senescence [43]
Comparison with experiments whose protocol does not include DNA damage
p38MAPK No damage: [1,2] loss of proliferation; [3] apoptosis
With damage: [1,2] senescence enhanced & loss of apoptosis; [3] apoptosis
Senescence [36]
CHEK1 No damage: loss of proliferation
With damage: similar to the wild type
?
p14ARF No damage: proliferation
With damage: apoptosis
Apoptosis [43]
p16INK4a No damage: cell cycle arrest with probability ~ 0.9
With damage: [1,2] similar to the wild type; [2] senescence enhanced
Proliferation decreased or senescence
[6,7,21]
p53 No damage: [1,2] loss of proliferation; [2] apoptosis
With damage: [1] senescence enhanced & loss of apoptosis; [2]: apoptosis
Apoptosis [4,48]
ATM No damage: [1] loss of proliferation; [2] senescence
With damage: [1] loss of senescence & apoptosis; [2] senescence enhanced
?
ATR No damage: [1,2] loss of proliferation
With damage: [1] senescence enhanced & loss of apoptosis; [2] loss of senescence & apoptosis
enhanced
Senescence [32]
CDC25A No damage: [1,2] proliferation
With damage: [1,2] loss of senescence
Proliferation [49]
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It is worth recalling that with cell culture experiments
that are currently available, one cannot know in which
checkpoint (G1/S or G2/M) the decision is taken. Further-
more, results only provide the predominant fate among
cell populations. Still, our comparisons between experi-
mental observations and the behaviour of our cellular
model are qualitatively valid in terms of trend with regard
to cell fate. Moreover, we include some predictions of the
model that remain to be experimentally tested.
p38MAPK knockout decreases apoptosis in mouse
fibroblasts [35] whereas its gain-of-function induces
senescence in human fibroblasts [36]. Our model out-
comes are compatible with these observations.
CHEK2 loss-of-function simulation abrogates senes-
cence, similar to what is seen in thymocytes [37]. Further-
more, the model predicts that when SSB = 2, senescence is
induced, as observed in experiments [38]. CHEK2 gain-of-
function expression abrogates proliferation, also in agree-
ment with experiments where apoptosis and senescence
are enhanced in human DLD1 and HeLa cells [39,40].
Experiments of ATM knockout report a decrease of apop-
tosis in human endothelial cells (HUVEC cells) [41] while
our model abrogates it.
In our model, CHEK1 loss-of-function abrogates senes-
cence, in contrast with experiments that show an increase
of apoptosis [42]. However, this discrepancy is to be
expected since, beyond the difficulty of comparing such
experimental data with our model, CHEK1 is an essential
gene involved in other important functions, including the
homologous recombination repair and the regulation of
G2/M checkpoint, both not included in our model [42].
Gain-of-function experiments of p14ARF induce an
apoptotic phenotype in osteosarcoma cells [43]. Accord-
ingly, our model predicts an enhanced apoptosis in the
presence of DNA damage, whereas in the absence of
damage, proliferation is preserved.
In single cells and mutant mice, Mdm2 knockout
induces an apoptotic phenotype [44], which is obtained
by our model in the presence of DNA damage. Impor-
tantly, consistent with the experimental literature, the
model shows that lethality of Mdm2 knockout can be
rescued by deleting p53 [45]. Finally, in agreement with
our model, ectopic expression of Mdm2 abrogates apop-
tosis in mice cells [46].
In the case of p16INK4a loss-of-function, there is no
stable senescent state, as observed experimentally in
several cell types, in which, in absence as well as in pre-
sence of DNA damage, p16INK4a gain-of-function induces
arrest and senescence enhancement [4,7,21]. Gain-of-func-
tion of p16INK4a (maintained positive, between 1 and 2)
displays multi-stability in the absence of DNA damage,
with two possible fates (proliferation and cycle arrest). By
sampling the state space through 104 random simulations
(see Methods), we obtained that the probability of cycle
arrest is >0.90. The model thus reproduces the prolifera-
tion decrease, but senescence enhancement is only
obtained in the presence of DNA damage, with p16INK4a
maintained constant at level 2.
In agreement with the model outcomes, p21 loss-of-
function induces proliferation in cancer cell lines, while
its ectopic expression abrogates proliferation or
induces senescence in human cells and mouse fibro-
blasts [6,47].
p53 knockout induces proliferation and abrogates
senescence in some cell types [7], which is consistent
with the model outcomes. Additionally, p53 null mice
cells show enhanced proliferation and are tumour prone
[48]. p53 gain-of-function in mice cells induces an apop-
totic phenotype [48], an outcome also obtained with our
model.
Experiments of ATR gain-of-function report an
increase in senescence in mouse fibroblasts [32], compa-
tible with our model predictions.
In mice fibroblasts, CDC25A loss-of-function and gain-
of-function respectively induce or prevent checkpoint
arrest [49]. Accordingly, for CDC25A loss-of-function, the
model predicts loss of proliferation in the absence of DNA
damage. Interestingly, in the presence of DNA damage,
the model predicts senescence enhancement for CDC25A
loss-of-function, an outcome previously hypothesized [49].
Tissues of RB1 null mice show increased apoptosis
while RB1 gain-of-function decreases proliferation
[48,50], both phenotypes are recovered by our model.
The model predicts that E2F loss-of-function abrogates
proliferation, in agreement with the observation that
human fibroblasts arrest or do not proliferate without E2F
[51]. E2F gain-of-function induces apoptosis [51], an out-
come reproduced by the model in the presence of DNA
damage.
Importantly, our model fairly reproduces the observa-
tion that a double knockout of Mdmd2 and p53 rescues
lethality of Mdm2 knockout [45].
Table 3 Comparison of model outcomes with experiments for different perturbations (Continued)
RB1 No damage: loss of proliferation
With damage: similar to the wild type
Cycle arrest [48]
E2F No damage: proliferation
With damage: apoptosis
Apoptosis [51]
Distinction is made between experiments that include DNA damage or not (see Supplementary material). Question marks indicate cases for which no data were
found.
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Conclusion
In summary, we have defined a precursory logical model
for the G1/S checkpoint where ATR and ATM pathways
activation by single and double DNA strand breaks is
sufficient to determine three different cell fates: cell
cycle arrest, apoptosis and senescence. ATM/ATR-
p38MAPK pathway in our model regulates the senescent
fate decision.
Despite a crude abstraction, our model accounts for
most experimental evidences, especially regarding the
senescent cell fate. Although this phenotype can depend
on the cell type, some mutations affecting this state are
observed in numerous cell types and reproduced by our
model; for instance, the senescent arrest arises from over-
expression of p16INK4a [4,7] and its abrogation from p21
or p16INK4a inactivation [7]. Interestingly, the model pre-
dicts that CDC25A knockout enhances senescence, an
outcome that could lead to a relevant target for interven-
tion in cancer [49].
At first glance, the model stable states seem to depend
on the sole value of p38MAPK (see Figure 2). Indeed, the
logical rules defining p38MAPK values perfectly match the
dependence of the fates to the levels of DSB and SSB.
Obviously, this is not the case: the sole value of p38MAPK
is not enough to determine the resulting cellular fate. This
is demonstrated through perturbation analyses: p38MAPK
loss-of-function leads to cell-cycle arrest phenotypes in
addition to the proliferative state; for a mild ectopic
expression of p38MAPK, a senescent state appears in
addition to the expected cell-cycle arrest outcome; finally,
a p38MAPK ectopic expression at level 2 leads to the cell-
cycle arrest phenotypes, besides the senescent outcome. It
is only when p38MAPK is maintained at its level 3 that we
have the sole apoptotic outcome.
Moreover, our model displays neither multi-stability
(unless in the case of p16INK4a gain-of-function), nor stable
oscillations. This can be explained through the analysis of
its regulatory circuits. Indeed, regulatory circuits are
known to be responsible for the emergence of dynamical
properties; negative circuits (i.e. encompassing an odd
number of inhibitions) are related to oscillations, whereas
positive circuits (with an even number of inhibitions)
induce multi-stability [52-54]. The (sole) positive circuit of
the network encompasses CDK2CycE, RB1 and E2F and
has a functionality context in which the system cannot be
maintained. Noteworthy, if p16INK4a is maintained at a
positive level (1 or 2), this functionality context is stable
when DSB=SSB = 0 and indeed, there is multi-stability
under this stress condition, with two stable states differing
by their values of the circuit members.
The lack of p53 oscillations that are involved in the
choice of cell fate [15] can be viewed as a limitation of
the model. These oscillations are driven by the negative
circuit (p53, Mdm2), known to produce a p53 oscillatory
response to DNA damage (e.g. [55]). A closer look to
p53 logical function indicates why this circuit is not
functional in our model (i.e. does not produce stable
oscillations [54,56]). The interaction from Mdm2 to p53
selects p53 levels between 1 and 2 (i.e. a total inactiva-
tion of p53 does not depend on Mdm2), whereas the
threshold of the interaction from p53 to Mdm2 is 1.
This points towards a potential revision of the model to
account for this oscillatory behaviour.
Future extensions include the consideration of compo-
nents involved in the G2/M checkpoint in response to
DNA damage [2,8]. Moreover, the model could be
improved by incorporating NF-KB, involved in inflamma-
tory responses and having an anti-apoptotic function in
DNA damage response [4,18]. For simplicity, mitogen-
activated protein kinase pathways are partly embodied in
p38MAPK in our model. Due to their important role in
stress-induced cell fate decisions, it would be valuable to
extend our model with this network, e.g. relying on the
logical model recently published by Grieco et al. [20].
Methods
We relied on the generalised logical formalism, initially
proposed by R. Thomas and colleagues [57-59]. Here, we
briefly describe this modelling framework, typical model
properties and the computational tool used to perform
model analysis (see e.g. [52,59] for further detail).
Briefly, a logical model is defined by a regulatory graph,
by discrete variables associated with the components and
rules specifying the evolution of these variables. Nodes in
a regulatory graph represent molecular components
(genes, proteins, complexes, etc.), processes or phenomen-
ological events (e.g. proliferation, cell-cycle arrest, stress,
etc.). Edges embody regulatory effects (activations or inhi-
bitions). Variables represent activity levels (Boolean or
multi-valued). Although Boolean variables (0 or 1) are
generally enough, a multi-valued variable can be associated
with a component to convey different effects upon its
targets.
The level of each component evolution is defined by a
logical rule that depends on the regulators of this com-
ponent. Input components (that are not regulated and
that embody extrinsic conditions) are considered
constant.
The (discrete) dynamical behaviours of logical models
are defined in terms of state transition graphs, where
nodes represent states (vectors encompassing the com-
ponents levels), and arcs represent state transitions.
Transitions from a state to its successors are defined by
the changes in component levels dictated by the logical
rules. Terminal strongly components of state transition
graphs correspond to attractors, either stable states or
cyclic complex attractors; these are (sets of) state(s) that
once reached, cannot be left. In particular, a stable state
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has no successor state since all component levels are
stable.
Several updating schemes can be considered, the most
common being the synchronous and the asynchronous
schemes [57,59]. For the model presented here that has
a unique stable state for each (fixed) combination of
DNA damage values, the choice of the updating scheme
has no impact, as the system will ultimately reach this
sole attractor. This is not the case when multiple attrac-
tors exist; in this case the asynchronous update is more
biologically founded [57]. We have recently developed
means to characterise attractor’s reachability (manu-
script in preparation). By sampling the state space
through adapted Monte Carlo simulations, we can esti-
mate the probability associated to each attractor. We
applied this new approach to evaluate the probability
associated to the proliferative and cycle-arrest attractors
for ectopic expression of p16INK4a (see Results).
The logical framework conveniently supports the quali-
tative nature of current knowledge of most signalling and
regulatory mechanisms. Interestingly, implicit notion of
time and asynchronous updating schemes allow the con-
sideration of diverse molecular processes associated with
different time scales in a single model, from transcriptional
regulation to protein phosphorylation [60]. The logical
approach further allows an easy, systematic analysis of per-
turbations, which amount to keeping a variable to its low-
est levels (loss-of-function experiment) of to its positive
levels (gain-of-function experiment).
The framework is implemented in the software tool
GINsim (http://ginsim.org), which offers a variety of
functionalities to analyse logical models [61]. In particu-
lar, it provides an efficient determination of the stable
states of a model.
Regulatory circuit analysis allows to pinpoint circuits
that play a crucial role in the emergence of dynamical
properties [53,54,56]; negative circuits (i.e. encompassing
an odd number of inhibitions) are required for oscilla-
tions, whereas positive circuits (encompassing an even
number of inhibitions) are required for multi-stability.
GINsim provides the functionality context (if not empty)
of each circuit. This context defines a region in the state
space where the circuit generates the expected property
(multi-stability or sustained oscillations) [62,63].
Finally, the model file is made available, together with
its documentation in the Supplementary material 2to
this article.
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